# Pharmacokinetic Drug Interaction Study in Healthy Male Subjects

> **NCT01426906** · PHASE1 · COMPLETED · sponsor: **LG Life Sciences** · enrollment: 24 (actual)

## Conditions studied

- Healthy Male Volunteers

## Interventions

- **DRUG:** Ketoconazole
- **DRUG:** rifampicin

## Key facts

- **NCT ID:** NCT01426906
- **Lead sponsor:** LG Life Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2011-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01426906

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01426906, "Pharmacokinetic Drug Interaction Study in Healthy Male Subjects". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01426906. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*